These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 30807551

  • 1. Formylated honokiol analogs showed antitumor activity against lung carcinoma.
    Deng S, Zhang C, Yang L, Ma L.
    Anticancer Drugs; 2019 Sep; 30(8):795-802. PubMed ID: 30807551
    [Abstract] [Full Text] [Related]

  • 2. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
    Tang H, Zhang Y, Li D, Fu S, Tang M, Wan L, Chen K, Liu Z, Xue L, Peng A, Ye H, Chen L.
    Eur J Med Chem; 2018 Aug 05; 156():190-205. PubMed ID: 30006164
    [Abstract] [Full Text] [Related]

  • 3. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model.
    Wen J, Fu AF, Chen LJ, Xie XJ, Yang GL, Chen XC, Wang YS, Li J, Chen P, Tang MH, Shao XM, Lu Y, Zhao X, Wei YQ.
    Int J Cancer; 2009 Jun 01; 124(11):2709-18. PubMed ID: 19219913
    [Abstract] [Full Text] [Related]

  • 4. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
    Ma L, Chen J, Wang X, Liang X, Luo Y, Zhu W, Wang T, Peng M, Li S, Jie S, Peng A, Wei Y, Chen L.
    J Med Chem; 2011 Oct 13; 54(19):6469-81. PubMed ID: 21853991
    [Abstract] [Full Text] [Related]

  • 5. Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer.
    Liu Y, Tong Y, Yang X, Li F, Zheng L, Liu W, Wu J, Ou R, Zhang G, Hu M, Liu Z, Lu L.
    Pharmacol Res; 2016 Sep 13; 111():113-125. PubMed ID: 27268146
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
    Zhao M, Zheng YH, Zhao QY, Zheng W, Yang JH, Pei HY, Liu L, Liu KJ, Xue LL, Deng DX, Wang L, Ma X, Fu SH, Peng AH, Tang MH, Luo YZ, Ye HY, Chen LJ.
    Eur J Med Chem; 2021 Jan 01; 209():112922. PubMed ID: 33069436
    [Abstract] [Full Text] [Related]

  • 7. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
    Huang KJ, Kuo CH, Chen SH, Lin CY, Lee YR.
    J Cell Mol Med; 2018 Mar 01; 22(3):1894-1908. PubMed ID: 29363886
    [Abstract] [Full Text] [Related]

  • 8. Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity.
    Hu J, Chen LJ, Liu L, Chen X, Chen PL, Yang G, Hou WL, Tang MH, Zhang F, Wang XH, Zhao X, Wei YQ.
    Exp Mol Med; 2008 Dec 31; 40(6):617-28. PubMed ID: 19116447
    [Abstract] [Full Text] [Related]

  • 9. A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies.
    Zhou C, Guo C, Li W, Zhao J, Yang Q, Tan T, Wan Z, Dong J, Song X, Gong T.
    Drug Dev Ind Pharm; 2018 Dec 31; 44(12):2005-2012. PubMed ID: 30058387
    [Abstract] [Full Text] [Related]

  • 10. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma.
    Chen F, Wang T, Wu YF, Gu Y, Xu XL, Zheng S, Hu X.
    World J Gastroenterol; 2004 Dec 01; 10(23):3459-63. PubMed ID: 15526365
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
    Hou W, Chen L, Yang G, Zhou H, Jiang Q, Zhong Z, Hu J, Chen X, Wang X, Yuan Y, Tang M, Wen J, Wei Y.
    Phytother Res; 2008 Aug 01; 22(8):1125-32. PubMed ID: 18570244
    [Abstract] [Full Text] [Related]

  • 14. Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS-4, a novel pro-apoptotic gene.
    Yuan Z, Liu H, Yan F, Wang Y, Gou L, Nie C, Ding Z, Lai S, Zhao Y, Zhao X, Li J, Deng H, Mao Y, Chen L, Wei Y, Zhao X.
    Cancer Sci; 2009 Sep 01; 100(9):1757-66. PubMed ID: 19575751
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
    Zhang Q, Zhao W, Ye C, Zhuang J, Chang C, Li Y, Huang X, Shen L, Li Y, Cui Y, Song J, Shen B, Eliaz I, Huang R, Ying H, Guo H, Yan J.
    Oncotarget; 2015 Nov 10; 6(35):37335-48. PubMed ID: 26484567
    [Abstract] [Full Text] [Related]

  • 17. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
    Hahm ER, Arlotti JA, Marynowski SW, Singh SV.
    Clin Cancer Res; 2008 Feb 15; 14(4):1248-57. PubMed ID: 18281560
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol.
    Luo Y, Xu Y, Chen L, Hu J, Peng C, Xie D, Shi J, Huang W, Xu G, Peng M, Han J, Li R, Yang S, Wei Y.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4702-5. PubMed ID: 19589678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.